Fortrea Holdings (FTRE) Other Working Capital Changes (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Other Working Capital Changes came in at -$6.1 million in Q2 2026, up 11.59% on a YoY basis from -$5.5 million in Q2 2025, and up 46.49% quarter-over-quarter from -$11.4 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Other Working Capital Changes for 5 consecutive years, with -$6.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Working Capital Changes rose 11.59% year-over-year to -$6.1 million; the trailing twelve-month figure through Jun 2026 stood at -$25.4 million (down 160.62% YoY), and the FY2025 full-year result was -$32.4 million, down 141.49% from the prior year.
- Other Working Capital Changes climbed to -$6.1 million in Q2 2026 per FTRE's latest filing, from -$11.4 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $72.2 million in Q3 2024 and bottomed at -$12.9 million in Q1 2023.
- Historically, Other Working Capital Changes has averaged $17.9 million across 5 years, with a median of $9.3 million in 2022.
- The widest YoY moves for Other Working Capital Changes: up 1020.0% in 2024, down 626.32% in 2024.
- Over 5 years, Other Working Capital Changes stood at -$5.9 million in 2022, then jumped by 167.8% to $4.0 million in 2023, then surged by 1020.0% to $44.8 million in 2024, then tumbled by 74.55% to $11.4 million in 2025, then slumped by 153.51% to -$6.1 million in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$6.1 million, -$11.4 million, and $11.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.10 Mn |
| Jun 30, 2026 | 22.10 Mn |
| Mar 31, 2026 | 6.60 Mn |
| Mar 31, 2026 | 6.60 Mn |
| Dec 31, 2025 | 60.20 Mn |
| Dec 31, 2025 | 60.20 Mn |
| Sep 30, 2025 | 31.40 Mn |
| Sep 30, 2025 | 31.40 Mn |
| Jun 30, 2025 | 12.80 Mn |
| Jun 30, 2025 | 12.80 Mn |
| Mar 31, 2025 | 10.40 Mn |
| Mar 31, 2025 | 10.40 Mn |
| Dec 31, 2024 | 33.60 Mn |
| Dec 31, 2024 | 33.60 Mn |
| Sep 30, 2024 | 72.20 Mn |
| Sep 30, 2024 | 72.20 Mn |
| Jun 30, 2024 | 7.80 Mn |
| Jun 30, 2024 | 7.80 Mn |
| Mar 31, 2024 | 26.40 Mn |
| Mar 31, 2024 | 26.40 Mn |